# OnCo record nct07479485 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct07479485/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct07479485", "NCT07479485" ;
  schema:name "MRG006A Combination Therapy for Advanced Hepatocellular Carcinoma (Phase I/II)"@en ;
  schema:description "A phase 1/2 trial of Pucotenlimab, Bevacizumab in hepatocellular carcinoma, run by Lepu Biopharma Co., Ltd., now recruiting."@en ;
  schema:url <https://onco.cc/trials/nct07479485/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT07479485> ;
  onco:status "recruiting" ;
  onco:tag "ctgov-ingest" ;
  onco:phase "1/2" ;
  schema:startDate "2026-04-08" ;
  onco:cancers <https://onco.cc/cancers/hcc/>, <https://onco.cc/cancers/hcc-advanced/> ;
  onco:drugs <https://onco.cc/drugs/pucotenlimab/>, <https://onco.cc/drugs/bevacizumab/> ;
  onco:companies <https://onco.cc/companies/lepu-biopharma/> .